Clinical Study
Timing of Hepatic Artery Reperfusion and Biliary Strictures in Liver Transplantation
Table 1
Descriptive characteristics of patients with and without biliary strictures undergoing OLT from 2007 to 2009.
| Variable | OLT without biliary strictures () | OLT with biliary strictures () | value |
| Age, years, mean ± sd (range) | (18.0–75.0) | (37.0–70.0) | 0.99 | Male, % () | 72.3 (47) | 80.0 (8) | 0.60 | Etiology, % () | | | | HCC | 27.7 (18) | 30.0 (3) | 0.57 | ALF/fulminant | 4.6 (3) | 10.0 (1) | 0.44 | HCV/ETOH | 4.6 (3) | 10.0 (1) | 0.44 | HCV | 21.5 (14) | 20.0 (2) | 0.63 | HBV | 3.1 (2) | 0.0 (0) | 0.75 | PSC | 3.1 (2) | 0.0 (0) | 0.75 | NASH | 3.1 (2) | 0.0 (0) | 0.75 | Cryptogenic | 10.8 (7) | 20.0 (2) | 0.34 | MELD, mean ± sd (range) | (6.0–44.0) | (6.0–48.0) | 0.42 | Graft survival, months, mean ± sd (range) | (3.0–45.0) | (12.0–40.0) | 0.99 | Alive, % () | 86.2 (56) | 90.0 (9) | 0.74 | PVRP-HARP, minutes, mean ± sd (range) | (10–189) | (26–119) | 0.81 | Warm ischemia time (WIT; minutes) mean ± sd (range) | (20–60) | (36–69) | 0.06 | Cold ischemia time (CIT; minutes) mean ± sd (range) | (38–756) | (277–631) | 0.03* |
|
|
Statistically significant.
|